Latest Australian Securities Exchange News

Euroz Hartleys, acting for Patronus Resources, has launched an unconditional on-market takeover bid for Matsa Resources at A$0.045 per share, aiming to acquire all shares not already controlled. The offer period runs from February 24 to March 24, 2025.

Cleo Diagnostics has responded to an ASX price query following a notable rise in its share price and trading volume, underscoring its patented ovarian cancer detection technology and ongoing U.S. clinical trials.

Cannindah Resources Limited has responded to an ASX price query, confirming no undisclosed information explains recent stock price movements and affirming compliance with continuous disclosure rules.

The Australian Office of Financial Management has issued a new 4.25% Treasury Bond due in 2036, set to begin trading on the ASX from February 13, 2025. This issuance adds a fresh long-term government debt instrument to the market.

Shekel Brainweigh Ltd has requested an immediate suspension from ASX quotation as it moves towards removal from the official ASX list, raising questions about the company’s future.

Eumundi Group Limited’s shares have been suspended from ASX trading following Federal Court approval of its acquisition by SEQ Hospitality Group Pty Ltd, marking a pivotal step in the company’s transition.

Betashares Mrtn Currie Real Income Fund (RINC) units were suspended from trading on the ASX on 4 February 2025, following a prior announcement in December 2024. This suspension marks a significant operational shift for the managed fund.

AustChina Holdings Limited has had its trading suspension lifted following the disclosure of a material acquisition, signaling a pivotal moment for the investment firm.

Viridis Mining and Minerals Limited has been reinstated to ASX quotation following a capital raising announcement, ending its trading suspension and signaling renewed investor confidence.

Mako Gold Limited’s securities have been suspended from ASX trading following Aurum Resources’ dispatch of compulsory acquisition notices, signaling a pivotal ownership transition.

Dateline Resources Limited’s shares were suspended from ASX trading on 3 February 2025 due to a delayed periodic report, raising questions about compliance and future market activity.

Argent BioPharma reports strategic cost-cutting moves including facility closures and delisting from the LSE, while securing German distribution approval and raising significant capital to support its drug pipeline.